高级搜索
谭芳春, 李力. 卵巢癌分子分型及其临床应用的研究进展[J]. 肿瘤防治研究, 2018, 45(2): 106-109. DOI: 10.3971/j.issn.1000-8578.2018.17.0771
引用本文: 谭芳春, 李力. 卵巢癌分子分型及其临床应用的研究进展[J]. 肿瘤防治研究, 2018, 45(2): 106-109. DOI: 10.3971/j.issn.1000-8578.2018.17.0771
TAN Fangchun, LI Li. Review of Molecular Subtyping of Ovarian Cancer and Its Clinical Application[J]. Cancer Research on Prevention and Treatment, 2018, 45(2): 106-109. DOI: 10.3971/j.issn.1000-8578.2018.17.0771
Citation: TAN Fangchun, LI Li. Review of Molecular Subtyping of Ovarian Cancer and Its Clinical Application[J]. Cancer Research on Prevention and Treatment, 2018, 45(2): 106-109. DOI: 10.3971/j.issn.1000-8578.2018.17.0771

卵巢癌分子分型及其临床应用的研究进展

Review of Molecular Subtyping of Ovarian Cancer and Its Clinical Application

  • 摘要: 卵巢癌是女性生殖系统第二常见的恶性肿瘤,存在高度异质性。卵巢癌分子分型概念的提出,为探索其异质性、预后评估及个体化治疗方案等方面提供了新依据。本文就卵巢癌的分子分型及临床应用的研究进展作一综述。

     

    Abstract: Ovarian cancer, with high heterogeneity, is the second common cancer in the female reproductive system malignancy tumors. The molecular typing of ovarian cancer has provided a new basis for exploring its heterogeneity, prognosis evaluation and individualized treatment regimen. This paper reviews the advances in molecular typing of ovarian cancer and its clinical application.

     

/

返回文章
返回